CA1310918C - Gamma irradiation of collagen/mineral mixtures - Google Patents

Gamma irradiation of collagen/mineral mixtures

Info

Publication number: CA1310918C
Authority: CA; Canada
Prior art keywords: collagen; mineral; radiation; linking; mixture
Prior art date: 1986-11-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000550940A

Other languages

English (en)

French (fr)

Inventor

Daniel Prows

Thomas L. Smestad

Diana M. Hendricks

George H. Chu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Collagen Aesthetics Inc

Original Assignee

Collagen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-06

Filing date

1987-11-03

Publication date

1992-12-01

1986-11-06 Priority claimed from US06/928,306 external-priority patent/US4865602A/en

1987-11-03 Application filed by Collagen Corp filed Critical Collagen Corp

1992-12-01 Application granted granted Critical

1992-12-01 Publication of CA1310918C publication Critical patent/CA1310918C/en

2009-12-01 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108010035532 Collagen Proteins 0.000 title claims abstract description 106
102000008186 Collagen Human genes 0.000 title claims abstract description 106
229920001436 collagen Polymers 0.000 title claims abstract description 102
239000000203 mixture Substances 0.000 title claims abstract description 70
229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 48
239000011707 mineral Substances 0.000 title claims abstract description 48
238000000034 method Methods 0.000 claims abstract description 30
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 17
239000001506 calcium phosphate Substances 0.000 claims description 16
229910000389 calcium phosphate Inorganic materials 0.000 claims description 13
235000011010 calcium phosphates Nutrition 0.000 claims description 13
238000001035 drying Methods 0.000 claims description 3
230000036512 infertility Effects 0.000 claims description 3
239000011363 dried mixture Substances 0.000 claims description 2
230000005855 radiation Effects 0.000 abstract description 33
230000001954 sterilising effect Effects 0.000 abstract description 19
238000004659 sterilization and disinfection Methods 0.000 abstract description 16
230000008569 process Effects 0.000 abstract description 13
239000000463 material Substances 0.000 description 29
238000002360 preparation method Methods 0.000 description 29
238000004132 cross linking Methods 0.000 description 21
230000000694 effects Effects 0.000 description 17
238000011282 treatment Methods 0.000 description 14
210000000988 bone and bone Anatomy 0.000 description 13
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 10
102000004142 Trypsin Human genes 0.000 description 9
108090000631 Trypsin Proteins 0.000 description 9
230000006835 compression Effects 0.000 description 9
238000007906 compression Methods 0.000 description 9
229910052588 hydroxylapatite Inorganic materials 0.000 description 8
230000000704 physical effect Effects 0.000 description 8
239000012588 trypsin Substances 0.000 description 8
239000006185 dispersion Substances 0.000 description 7
239000007943 implant Substances 0.000 description 7
230000008439 repair process Effects 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
230000035945 sensitivity Effects 0.000 description 6
230000003416 augmentation Effects 0.000 description 5
238000013467 fragmentation Methods 0.000 description 5
238000006062 fragmentation reaction Methods 0.000 description 5
238000010438 heat treatment Methods 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
239000000501 collagen implant Substances 0.000 description 4
230000007547 defect Effects 0.000 description 4
239000000047 product Substances 0.000 description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
210000001909 alveolar process Anatomy 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
230000005847 immunogenicity Effects 0.000 description 3
239000012535 impurity Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000008520 organization Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
230000007704 transition Effects 0.000 description 3
229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
235000019731 tricalcium phosphate Nutrition 0.000 description 3
229940078499 tricalcium phosphate Drugs 0.000 description 3
241000282693 Cercopithecidae Species 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
241000906034 Orthops Species 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
239000012620 biological material Substances 0.000 description 2
230000008468 bone growth Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000000113 differential scanning calorimetry Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000000835 fiber Substances 0.000 description 2
-1 for example Chemical compound 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
238000002513 implantation Methods 0.000 description 2
230000003902 lesion Effects 0.000 description 2
229960004194 lidocaine Drugs 0.000 description 2
230000003239 periodontal effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000011148 porous material Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
238000007493 shaping process Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000282465 Canis Species 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
241000252095 Congridae Species 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
206010023146 Jaw cyst Diseases 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
241001274660 Modulus Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
208000006735 Periostitis Diseases 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010077465 Tropocollagen Proteins 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000004068 calcium phosphate ceramic Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
210000004262 dental pulp cavity Anatomy 0.000 description 1
238000010586 diagram Methods 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
239000012433 hydrogen halide Substances 0.000 description 1
229910000039 hydrogen halide Inorganic materials 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000013081 microcrystal Substances 0.000 description 1
238000005457 optimization Methods 0.000 description 1
239000011368 organic material Substances 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
238000012856 packing Methods 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
210000003460 periosteum Anatomy 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
230000005588 protonation Effects 0.000 description 1
239000012858 resilient material Substances 0.000 description 1
238000012552 review Methods 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000003239 susceptibility assay Methods 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Apparatus For Disinfection Or Sterilisation (AREA)

CA000550940A 1986-11-06 1987-11-03 Gamma irradiation of collagen/mineral mixtures Expired - Lifetime CA1310918C (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/928,306 US4865602A (en)	1986-11-06	1986-11-06	Gamma irradiation of collagen/mineral mixtures
US928,306		1986-11-06

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000616394A Division CA1320451C (en)	1986-11-06	1992-06-02	Gamma irradiation of collagen/mineral mixtures

Publications (1)

Publication Number	Publication Date
CA1310918C true CA1310918C (en)	1992-12-01

Family

ID=25456062

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000550940A Expired - Lifetime CA1310918C (en)	1986-11-06	1987-11-03	Gamma irradiation of collagen/mineral mixtures

Country Status (3)

Country	Link
AT (1)	ATE86505T1 (de)
CA (1)	CA1310918C (de)
DE (1)	DE3784646T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2529764A1 (de)	2011-05-31	2012-12-05	Curasan AG	Biologisch degradierbares kompositmaterial

1987
- 1987-11-03 CA CA000550940A patent/CA1310918C/en not_active Expired - Lifetime
- 1987-11-05 DE DE19873784646 patent/DE3784646T2/de not_active Expired - Fee Related
- 1987-11-05 AT AT87309810T patent/ATE86505T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE3784646T2 (de)	1993-06-17
DE3784646D1 (de)	1993-04-15
ATE86505T1 (de)	1993-03-15

Legal Events

Date	Code	Title	Description
2000-12-01	MKLA	Lapsed

Publication	Publication Date	Title
CA1320451C (en)	1993-07-20	Gamma irradiation of collagen/mineral mixtures
US5246457A (en)	1993-09-21	Xenogeneic collagen/mineral preparations in bone repair
EP0197693B1 (de)	1991-10-23	Xenogene Kollagen/Mineralzubereitungen zur Knochenreparatur
US4992226A (en)	1991-02-12	Method of making molds with xenogeneic collagen/mineral preparations for bone repair
US4774227A (en)	1988-09-27	Collagen compositions for bone repair containing autogeneic marrow
US4776890A (en)	1988-10-11	Preparation of collagen hydroxyapatite matrix for bone repair
AU593094B2 (en)	1990-02-01	Marrow/collagen/mineral matrix for bone defect repair
CA2318543A1 (en)	1999-08-05	Bone paste subjected to irradiative and thermal treatment
WO2019115795A1 (en)	2019-06-20	Dried implant composition and injectable aqueous implant formulation
EP0550458B1 (de)	1995-07-12	Knochenwachstumsstimulator
US6406711B1 (en)	2002-06-18	Bone regeneration material
CA1310918C (en)	1992-12-01	Gamma irradiation of collagen/mineral mixtures
US6884518B2 (en)	2005-04-26	Material suitable for an individual's tissue reconstruction
de CARVALHO et al.	1987	Biocompatibility of a Resilient Resin A Histological Study in Rats
Kandasamy et al.	2011	Preparation and Use of Fibrin Composite as a Hard Tissue Graft Material: An Animal Study
JPH01171559A (ja)	1989-07-06	生体材料